Selective Serotonin Reuptake Inhibitors Plus Phosphodiesterase-5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis

Urology

Volumn 86, Issue 4, 2015, Pages 758-765

  Bai, Yunjin ^a   Pu, Chunxiao ^a   Han, Ping ^a   Li, Jinhong ^a   Yuan, Haichao ^a,b   Tang, Yin ^a   Wang, Xiaoming ^a   Wei, Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SEROTONIN UPTAKE INHIBITOR; PHOSPHODIESTERASE V;

ARTICLE; CLINICAL STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LATENT PERIOD; MALE; META ANALYSIS; PREMATURE EJACULATION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SEXUAL SATISFACTION; SYSTEMATIC REVIEW; DRUG COMBINATION; DRUG EFFECTS; EJACULATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DRUG THERAPY, COMBINATION; EJACULATION; HUMANS; MALE; PREMATURE EJACULATION; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84942991373     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.06.045     Document Type: Article

References (31)

1. E.C. Serefoglu, O. Yaman, S. Cayan, and et al. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey J Sex Med 8 2011 540 548
2. J. Gao, X. Zhang, P. Su, and et al. Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in China J Sex Med 10 2013 1874 1881
3. O. Shaeer The global online sexuality survey (GOSS): The United States of America in 2011 Chapter III-premature ejaculation among English-speaking male Internet users J Sex Med 10 2013 1882 1888
4. S.E. Althof, C.G. McMahon, M.D. Waldinger, and et al. An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE) J Sex Med 11 2014 1392 1422
5. C. Pu, L. Yang, L. Liu, and et al. Topical anesthetic agents for premature ejaculation: a systematic review and meta-analysis Urology 81 2013 799 804
6. J.H. Lee Associations between premature ejaculation, lower urinary tract symptoms, and erectile dysfunction in middle-aged Korean policemen J Sex Med 11 2014 1512 1518
7. A. Gökçe, F. Halis, A. Demirtas, and et al. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study BJU Int 107 2011 1274 1277
8. M.J. Mathers, T. Klotz, S. Roth, and et al. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study Andrologia 41 2009 169 175
9. M.J. Dresser, D. Desai, S. Gidwani, and et al. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors Int J Impot Res 18 2006 104 110
10. M.M. Hosseini, and H. Yarmohammadi Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation Urol Int 79 2007 28 32
11. W.K. Lee, S.H. Lee, S.T. Cho, and et al. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study J Sex Med 10 2013 2832 2841
12. R.M. Mattos, A. Marmo Lucon, and M. Srougi Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study Urol Int 80 2008 162 165
13. E.C. Polat, E. Ozbek, A. Otunctemur, and et al. Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation Andrologia 47 2015 487 492
14. T.D. Burton, and C. Liday The comparison of combination SSRI and PDE-5 inhibitor therapy to SSRI monotherapy in men with premature ejaculation Ann Pharmacother 45 2011 1000 1004
15. A.D. Asimakopoulos, R. Miano, E. Finazzi Agrò, and et al. Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta-analysis J Sex Med 9 2012 2404 2416
16. A.R. Jadad, R.A. Moore, D. Carroll, and et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
17. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13 22
18. X.S. Zhang, Y.X. Wang, X.Y. Huang, and et al. Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation Zhonghua Nan Ke Xue 11 2005 520 522 525
19. C.G. McMahon, F. Giuliano, J. Dean, and et al. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study J Sex Med 10 2013 2312 2325
20. E.C. Serefoglu, N. Direk, and W.J. Hellstrom Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-pacific region-a comment J Sex Med 9 2012 1488 1489
21. H. Porst, F. Montorsi, R.C. Rosen, and et al. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking Eur Urol 51 2007 816 823
22. S. Uckert, M. Oelke, C.G. Stief, and et al. Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate Eur Urol 49 2006 740 745
23. S. Uckert, S. Bazrafshan, F. Scheller, and et al. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors Urology 70 2007 185 189
24. A. Sansone, F. Romanelli, E.A. Jannini, and et al. Hormonal correlations of premature ejaculation Endocrine 49 2015 333 338
25. M.D. Waldinger Premature ejaculation: state of the art Urol Clin North Am 34 2007 591 599
26. L.J. Kriegsfeld, G.E. Demas, P.L. Huang, and et al. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-) Physiol Behav 67 1999 561 566
27. J.S. Chan, E.M. Snoeren, E. Cuppen, and et al. The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats J Sex Med 8 2011 97 108
28. C.G. McMahon Pharmacological treatment of ejaculatory disorders J Sex Med 1 Suppl 1 2004 19 21
29. J. Buvat, F. Tesfaye, M. Rothman, and et al. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries Eur Urol 55 2009 957 967
30. R. Shabsigh, D.L. Patrick, D.L. Rowland, and et al. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine BJU Int 102 2008 824 828
31. J. Li, H. Yuan, Y. Bai, and et al. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials Clin Ther 36 2014 2003 2014